All Pharma articles – Page 15
-
Expert BriefingThe Commissioner: 'Difficult choices' run out of steam
What NHS England isn’t telling you, and more indispensable weekly insight for commissioners, by Dave West.
-
NewsCQC criticises 'unsafe' digital GP service
The Care Quality Commission has uncovered unsafe prescribing practises at another digital health provider, including a doctor prescribing sleeping disorder drug to keep a person awake for work.
-
NewsFormer DH chief to lead alliance to stand up for NHS in Brexit talks
Former DH permanent secretary Sir Hugh Taylor to co-chair Brexit Health Alliance with NHS Confederation chief executive Niall Dickson Alliance will aim to safeguard NHS interests as the UK government negotiates Brexit Calls for the government to make commitments on research and funding An alliance of healthcare industry, ...
-
NewsSecond court defeat for NHS England
NHS England faces judicial review over decision not to fund drug for 7-year-old boy Lawyers will argue NHSE should have considered the boy’s welfare under the Children Act Victory could create a new duty on NHS England when making commissioning decisions affecting children Lawyers have been granted permission ...
-
NewsExclusive: NICE to routinely review drugs' budget impact for NHS England
NICE asked by NHS England to analyse the “finance impact” of new potential treatments Second programme in which a NICE review of treatment costs could potentially impact access NICE will grade clinical evidence available for each treatment, which may impact rare disease medicines The National Institute for Health ...
-
NewsNew alliance to fight NHS's corner during Brexit talks
Alliance of NHS organisations to speak up for the health service to be announced within the month NHS Confederation behind the plan, which will not argue for or against Brexit The group will aim to ensure issues affecting NHS are recognised by government An alliance of NHS organisations ...
-
CommentWe must act as England falls behind on access to rare disease medicines
It is crucial that we develop a bespoke process to evaluate ‘orphan’ medicines if we are to eradicate inequality in the system, says Sebastian Stachowiak
-
NewsTrust and royal college raise concerns over drug savings drive
Drug used for pain management in palliative and cancer care included in NHS England list of drugs up for review The Christie medical director says NHS would be doing a “disservice” to patients if it withdrew use of fentanyl Royal college specialist raises concerns the review will lead to ...
-
NewsSpecialised commissioning process 'lacks transparency', NHS England told
Specialised commissioning is “very hard to probe”, resulting in “unusual decisions”, stakeholders warn NHS England made funding U-turn on two treatments it had previously deemed “unaffordable” but provided little detail about why FOI request for minutes of specialised commissioning funding body denied ABPI says “major reassessment” of whole process ...
-
HSJ KnowledgeCancer drugs webinar: How to put a value on the priceless
A webinar in association with Roche brought together senior figures to consider how we assess the value of sophisticated drugs when the area is such an intellectual and moral maze. Report by Claire Read
-
NewsExclusive: Stevens backs major £400m medicines savings drive
NHS England backs plan to eliminate prescribing of “low priority” medicines worth up to £400m Commissioners to tackle spending on “low priority” medicines including gluten-free products and paracetamol that can be bought over the counter First phase of plan looks to eliminate £128m spending on 10 items Commissioning leader ...
-
NewsNICE goes ahead with controversial drug affordability test
NICE approves plans to defer treatment implementation if the cost per year is higher than £20m in any of the first three years of implemention Consultation responses warn that this could lead to treatment access “inequity” especially for those with rare diseases New “light touch” fast-track appraisal method also ...
-
NewsCourt defeat moves NHS England to clarify treatments policy
NHS England says court case has led to confusion among funding request applications Judge said last year that NHS England policy was “absurd” New policy will set out clear guidance on exceptionality test for patients NHS England says it will clarify its policy on commissioning treatments for patients ...
-
News'Wholly inappropriate' NHS England appeal thrown out of court
NHS England loses Court of Appeal bid and must pay costs Father accuses national commissioning body of “bully boy” approach Judge says there was “no good reason in the public interest” for the appeal to proceed NHS England is facing a £200,000 legal bill after pursuing a court ...
-
News
CCG warns against pharma giant's vaccine offer
Dudley CCG warns GPs over buying discounted vaccines directly from Sanofi The manufacturer is offering GPs a 50 per cent discount on flu vaccines GPs are then reimbursed by the NHS Business Services Authority at full price CCG says this may have “negative” impact for taxpayers Commissioners in ...
-
CommentPreparing for the impact of Brexit on health in the UK
In the aftermath of Brexit, it is essential that the NHS gain public support for the continued recruitment of clinical and scientific staff from the EU
-
HSJ KnowledgeHow specialist nurses can bring services closer to home
Shrewd service redesign by specialist nurses can lead to greater efficiency for providers and better care for patients
-
HSJ KnowledgeSpecialist nurses support cost effective drugs for treatment
Specialist IBD nurses are key to ensuring cutting edge biological therapies are used in a way which benefits both trust and patient
-
CommentReframing frailty care – what can we learn from mental health?
Four challenges must be overcome if society and NHS decision makers are to heed the valuable lessons from another sector
-
HSJ KnowledgeRoundtable: Jumping the hurdles to better care in rare diseases
An HSJ roundtable sponsored by Shire brought together experts to ask whether the NHS was taking advantage of all the factors that could improve outcomes for patients with rare diseases. By Alison Moore